Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Fluoropyridine | HCID 9746 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | HCID 136504489 | HCID 136504489 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 136504481 | HCID 136504481 | 41.1% |
Reaction Steps
Into a 25-mL round-bottom flask, was placed a solution of tert-butyl (3R)-3-[[5-(1,3-benzothiazol-2-yl)-6-oxo-2-(piperidin-4-yl)-1,6-dihydropyrimidin-4-yl]amino]piperidine-1-carboxylate (150 mg, 0.29 mmol, 1.00 equiv) in N,N-dimethylformamide (5 mL) and 2-fluoropyridine (114 mg, 1.17 mmol, 4.00 equiv). This was followed by the addition of potassium carbonate (81 mg, 0.59 mmol, 2.00 equiv). The resulting solution was stirred for 24 h at 100° C. The solids were filtered out. The resulting mixture was concentrated under reduced pressure. The residue was purified through a silica gel column with dichloromethane/methanol (50:1-20:1) to afford 70 mg of tert-butyl (3R)-3-[[5-(1,3-benzothiazol-2-yl)-6-oxo-2-[1-(pyridin-2-yl)piperidin-4-yl]-1,6-dihydropyrimidin-4-yl]amino]piperidine-1-carboxylate as a light yellow solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09221809B2 |
|---|
| Source dataset | uspto-grants-2015_12 |
|---|
| ORD ID | ord-3d10145ac3ee40a9b8b42cd2b5102243 |
|---|
| Source note | uspto-grants-2015_12 |
|---|